You just read:

Nektar Therapeutics Presents Clinical Data from Phase 3 SUMMIT-07 Study of NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2017 PAINWeek®

News provided by

Nektar Therapeutics

Sep 06, 2017, 18:00 ET